Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1993 1
2002 3
2003 3
2004 3
2006 2
2007 2
2008 5
2009 1
2010 6
2011 9
2012 6
2013 9
2014 5
2015 9
2016 6
2017 11
2018 5
2019 3
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
Das NA, Carpenter AJ, Belenchia A, Aroor AR, Noda M, Siebenlist U, Chandrasekar B, DeMarco VG. Das NA, et al. Among authors: demarco vg. Cell Signal. 2020 Apr;68:109506. doi: 10.1016/j.cellsig.2019.109506. Epub 2019 Dec 17. Cell Signal. 2020. PMID: 31862399 Free PMC article.
The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.
Sukhanov S, Higashi Y, Yoshida T, Mummidi S, Aroor AR, Jeffrey Russell J, Bender SB, DeMarco VG, Chandrasekar B. Sukhanov S, et al. Among authors: demarco vg. Cell Signal. 2021 Jan;77:109825. doi: 10.1016/j.cellsig.2020.109825. Epub 2020 Nov 4. Cell Signal. 2021. PMID: 33160017
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, Martinez-Lemus L, Manrique-Acevedo CM, Hayden MR, Duta C, Nistala R, Mayoux E, Padilla J, Chandrasekar B, DeMarco VG. Aroor AR, et al. Among authors: demarco vg. Cardiovasc Diabetol. 2018 Jul 30;17(1):108. doi: 10.1186/s12933-018-0750-8. Cardiovasc Diabetol. 2018. PMID: 30060748 Free PMC article.
Vascular stiffness in insulin resistance and obesity.
Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA, Sowers JR. Jia G, et al. Among authors: demarco vg. Front Physiol. 2015 Aug 14;6:231. doi: 10.3389/fphys.2015.00231. eCollection 2015. Front Physiol. 2015. PMID: 26321962 Free PMC article. Review.
Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.
Pulakat L, DeMarco VG, Ardhanari S, Chockalingam A, Gul R, Whaley-Connell A, Sowers JR. Pulakat L, et al. Among authors: demarco vg. Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R885-95. doi: 10.1152/ajpregu.00316.2011. Epub 2011 Aug 3. Am J Physiol Regul Integr Comp Physiol. 2011. PMID: 21813874 Free PMC article. Review.
84 results